Drug Shortage Report for SANDOZ TRANDOLAPRIL

Last updated on 2025-04-15 History
Report ID 249999
Drug Identification Number 02325756
Brand name SANDOZ TRANDOLAPRIL
Common or Proper name TRANDOLAPRIL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TRANDOLAPRIL
Strength(s) 2MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100HGC BO
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-02-10
Estimated end date 2025-04-11
Actual end date 2025-04-14
Shortage status Resolved
Updated date 2025-04-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-04-15 English Compare
v7 2025-04-14 French Compare
v6 2025-04-14 English Compare
v5 2025-02-24 French Compare
v4 2025-02-24 English Compare
v3 2025-02-11 English Compare
v2 2025-02-10 French Compare
v1 2025-02-10 English Compare

Showing 1 to 8 of 8